The GCC medical gloves market is valued at USD 174.15 million in 2025 and is poised to reach USD 218.61 million by 2035, expanding at a CAGR of 2.3%. The market continues to be driven by increasing healthcare expenditure, growing awareness of hygiene practices, and stringent infection control protocols across hospitals, clinics, and diagnostic laboratories.
The rising number of surgical procedures and outpatient treatments is also contributing to consistent glove consumption. In addition, the ongoing expansion of healthcare infrastructure, combined with population growth and government efforts to enhance healthcare quality, is supporting steady demand for high-performance disposable gloves across the GCC.
Government regulations across the GCC medical gloves market are becoming more stringent to ensure superior standards of safety and quality. Regulatory bodies such as the Saudi Food and Drug Authority (SFDA), UAE Ministry of Health and Prevention, and the Gulf Standards Organization (GSO) have implemented mandatory certification and rigorous testing requirements.
All imported and domestically manufactured medical gloves must comply with ISO 11193 and EN 455 standards for single-use medical gloves, covering barrier integrity, biocompatibility, and shelf life. Moreover, national procurement policies increasingly favor locally certified manufacturers, fostering supply chain resilience and encouraging domestic production. GCC nations are also advancing green healthcare policies, promoting sustainable and biodegradable glove materials in alignment with global environmental objectives.
Looking ahead, the GCC medical gloves market is likely to witness a shift towards biodegradable and eco-friendly glove options as part of broader sustainability initiatives. Technological advancements in antimicrobial glove coatings and enhanced barrier protection are likely to create new avenues for growth. The market is also expected to benefit from government-backed incentives to promote local manufacturing, reducing import dependency. Additionally, rising demand from medical tourism and pandemic preparedness programs is likely to further accelerate the consumption of high-quality medical gloves across the region from 2025 to 2035.
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 174.15 million |
| Industry Value (2035F) | USD 218.61 million |
| CAGR (2025 to 2035) | 2.3% |
The market is segmented based on product type, packaging state, material type, usage, distribution channel, end user, and region. By product type, the market is divided into examination gloves, surgical gloves, and chemotherapy gloves. In terms of packaging state, it is segmented into powdered gloves and powder-free gloves. Based on material type, the market is categorized into latex, nitrile rubber, vinyl rubber, and polyisoprene.
By usage, the market is segmented into disposable and reusable gloves. In terms of distribution channel, it is classified into offline and online channels. Based on end user, the market is categorized into hospitals, clinics, ambulatory surgery centres, diagnostic centres, rehabilitation centres, and others (home healthcare providers, long-term care facilities, emergency medical services (EMS), and military medical units). Regionally, the market is classified into Saudi Arabia, United Arab Emirates (UAE), Kuwait, Qatar, Oman, and Bahrain.
The chemotherapy gloves segment is witnessing strong demand, driven by the rising incidence of cancer across the GCC, particularly in Saudi Arabia and the UAE, where oncology care infrastructure is expanding. Handling of cytotoxic drugs necessitates gloves with enhanced chemical resistance and barrier performance. Growing awareness among healthcare professionals about the risks of drug permeation is fueling demand for specialized chemotherapy gloves made of nitrile and advanced polymer blends. Stringent occupational safety regulations are further accelerating adoption across oncology departments and chemotherapy wards.
Meanwhile, examination gloves are projected to hold 67.5% share of total sales in 2025, maintaining dominance despite rising demand for chemotherapy and specialty gloves. Examination gloves and surgical gloves continue to dominate market volumes due to their widespread use in general diagnostics, outpatient procedures, and surgical interventions.
Powder-free gloves are gaining significant traction, replacing powdered variants amid increasing regulatory restrictions. By material, nitrile gloves are witnessing robust uptake driven by latex allergy concerns and superior chemical resistance. The disposable gloves segment remains critical for infection control, particularly post-COVID. Offline distribution channels remain the primary sales avenue, though online procurement is expanding rapidly. Among end users, hospitals hold the largest share, but ambulatory surgery centres and home healthcare providers are emerging as dynamic growth areas amid shifts toward outpatient and personalized care delivery.
| Product Type Segment | Market Share (2025) |
|---|---|
| Examination Gloves | 67.5% |
The powder-free gloves segment is projected to grow at the fastest CAGR of 6.9% from 2025 to 2035. Increasing concerns over allergic reactions, coupled with regulatory restrictions on powdered gloves in healthcare settings, are driving this growth. Across GCC countries, heightened infection control standards and a growing emphasis on patient safety are fueling demand for non-irritant materials in both surgical and diagnostic applications. Powder-free gloves especially nitrile and latex variants have become more cost-effective due to advancements in production technologies, making them the preferred choice across hospitals, outpatient clinics, and home healthcare services.
In contrast, powdered gloves are experiencing a steady decline, finding limited application mainly in niche industrial or lower-risk medical environments where cost sensitivity still influences procurement decisions. Their use in frontline healthcare is diminishing as GCC regulatory frameworks increasingly align with global best practices that discourage powdered glove usage due to associated health risks. Additionally, growing investments in powder-free gloves suitable for cleanroom and high-sterility environments are accelerating the transition.
As healthcare systems across the region continue modernizing and prioritizing hygiene, powder-free gloves are likely to cement their leadership position, supported by strong regulatory backing and shifting procurement preferences toward safer, higher-performing products.
| Packaging State Segment | CAGR (2025 to 2035) |
|---|---|
| Powder-Free Gloves | 6.9% |
The nitrile rubber segment is forecast to expand at the fastest CAGR of 8.2% from 2025 to 2035. The increasing incidence of latex allergies among patients and healthcare professionals across GCC hospitals is a key driver of this demand shift. Nitrile gloves provide superior chemical resistance, enhanced durability, and excellent tactile sensitivity, making them highly suitable for surgical, chemotherapy, and diagnostic applications. The post-pandemic stabilization of nitrile glove supply chains has further improved product availability and pricing, encouraging broader adoption across the healthcare ecosystem.
Conversely, latex gloves continue to address demand in cost-sensitive segments but are facing reduced usage in critical care settings due to allergy risks. Vinyl gloves remain preferred for low-risk, short-duration tasks, particularly in non-clinical environments; however, their lower durability and protective performance limit widespread healthcare use.
Polyisoprene gloves, which offer a latex-like feel without allergy risks, are steadily gaining traction in high-end surgical markets but remain cost-prohibitive for routine use. Moving forward, evolving hospital procurement strategies and regional regulatory frameworks across the GCC are likely to accelerate the adoption of nitrile gloves. As the focus on patient safety and material performance intensifies, nitrile gloves are poised to remain the material of choice in the region.
| Material Type Segment | CAGR (2025 to 2035) |
|---|---|
| Nitrile Rubber | 8.2% |
The disposable gloves segment is expected to grow at a CAGR of 6.3% from 2025 to 2035. Enhanced infection control practices and stringent hygiene standards across GCC hospitals, clinics, and diagnostic centers are driving demand for single-use gloves. Disposable gloves serve as the primary barrier against cross-contamination in both surgical and non-surgical environments, making them an indispensable part of medical protocols. The sustained emphasis on patient safety, combined with the increased frequency of outpatient procedures, home healthcare visits, and community health initiatives post-pandemic, is keeping demand resilient across all GCC markets.
In contrast, reusable gloves occupy a limited share of the market, mainly catering to non-critical functions such as cleaning and facility maintenance within healthcare settings. Although they offer clear environmental advantages by reducing waste, concerns related to sterilization efficacy, material wear over time, and evolving regulatory preferences favor the continued dominance of disposable gloves. The shift toward more stringent infection prevention practices further reinforce this preference. Meanwhile, technological innovations in biodegradable materials and eco-friendly glove designs are emerging. These advancements align with the GCC’s growing commitment to sustainable healthcare procurement and could provide additional growth avenues for the disposable glove segment during the forecast period.
| Usage Segment | CAGR (2025 to 2035) |
|---|---|
| Disposable Gloves | 6.3% |
The ambulatory surgery centres (ASC) segment is forecast to grow at the fastest CAGR of 8.5% from 2025 to 2035. The GCC region is witnessing a major shift toward outpatient and same-day surgical care, driven by cost-efficiency, convenience, and evolving healthcare reimbursement models. Saudi Arabia and the UAE are leading ASC investments, supported by public-private partnerships and the rise of specialized surgical clinics. Demand for high-quality medical gloves especially powder-free nitrile gloves is surging in ASCs to ensure strict infection control and protect against surgical complications.
The shift toward minimally invasive procedures are further fueling glove consumption in this segment. Meanwhile, hospitals remain the largest end user, accounting for substantial glove volumes across all departments. Clinics and diagnostic centres continue to be key users as outpatient diagnostics and preventive care services expand. Rehabilitation centres maintain steady glove usage in physiotherapy and infection prevention.
The others segment comprising home healthcare providers, long-term care facilities, emergency medical services (EMS), and military medical units is an emerging growth area, particularly as GCC governments promote at-home care for chronic disease management and post-surgical recovery. Enhanced hygiene standards and personalized patient care models will further accelerate glove demand across these alternative settings.
| End User Segment | CAGR (2025 to 2035) |
|---|---|
| Ambulatory Surgery Centres | 8.5% |
Favorable government-backed policies across the GCC countries for the expansion of the healthcare sector will continue fueling the growth of the industry over the assessment period. Moreover, patients from the West are traveling to Gulf countries due to ever-rising costs of medical procedures like dental, dermatology, orthopedic, and others in Europe and America.
In terms of raw material, the latex material is used for making more than 80% of the total medical gloves available in the Gulf Cooperation Council region. With improving trade relations of the regional countries the import of latex is expected to increase from South Asian countries resulting in the strengthening of the GCC latex glove industry.
The rise in allergic reactions due to the use of latex material used in gloves is compelling manufacturers to introduce new materials for better safety. As a substitute for natural latex, applications of nitrile gloves have increased and are expected to create new opportunities for growth for industry players in GCC countries.
The table below represents the discreet growth rates for different countries in the region.
| Regional Industry Comparison | CAGR (2025 to 2035) |
|---|---|
| Kingdom of Saudi Arabia | 3.8% |
| United Arab Emirates (UAE) | 4.0% |
| Qatar | 3.2% |
| Kuwait | 3.1% |
| Oman | 2.9% |
In 2025, the KSA is estimated to account for over 70% of the revenue share in the GCC countries. It is further expected to witness a CAGR of 3.8% from 2025 to 2035.
With the improvement in living standards, there is a growing need for medical gloves that are comfortable, long-lasting, and of excellent quality. The Saudi Arabian government is also encouraging the participation of international private players operating in the healthcare sector.
The sales of medical gloves in the United Arab Emirates are expected to rise at a rate of 4.0% during the projected years. UAE is expected to account for approximately 18% of the total industry share in GCC countries by 2035.
The proliferation of e-commerce platforms has increased access to medical gloves and is fostering the expansion of the sector. The rising prevalence of the medical tourism sector in the country is expected to favor the GCC surgical glove industry.
Demand for medical gloves in Qatar is expected to grow at a steady pace of 3.2% over the forecast period.
The rising prevalence of infectious diseases is expected to drive the demand for disposable medical gloves in the country. The industry is set to experience a positive growth outlook owing to the growing avenues of cosmetic surgical procedures within the region.
Sales of medical gloves in Kuwait are expected to rise at a rate of 3.1% between 2025 and 2035.
A growing number of hospital setups and clinics along with increasing foreign direct investments (FDI). The use of medical disposable gloves in the oil extraction sector of the country is expected to contribute noticeably to the medical glove industry in GCC.
Demand for medical gloves in Oman is anticipated to grow at a rate of 2.9% from 2025 to 2035.
Greater adoption of personal protective equipment in the country favors the healthcare glove sector in GCC. Growing production of latex and other materials used in the making of medical gloves is expected to bolster the regional industry.
| Report Attributes | Details |
|---|---|
| Current Total Market Size (2025) | USD 174.15 million |
| Projected Market Size (2035) | USD 218.61 million |
| CAGR (2025 to 2035) | 2.3% |
| Base Year for Estimation | 2024 |
| Historical Period | 2020 to 2024 |
| Projections Period | 2025 to 2035 |
| Quantitative Units | USD million for value and million units for volume |
| By Product Types | Examination Gloves, Surgical Gloves, and Chemotherapy Gloves |
| By Packaging State | Powdered Gloves, and Powder-Free Gloves |
| By Material Types | Latex, Nitrile Rubber, Vinyl Rubber, and Polyisoprene |
| By Usage | Disposable and Reusable Gloves |
| By Distribution Channels | Offline and Online |
| By End Users | Hospitals, Clinics, Ambulatory Surgery Centres, Diagnostic Centres, Rehabilitation Centres, and Others (Home Healthcare Providers, Long-term Care Facilities, Emergency Medical Services (EMS), Military Medical Units) |
| Countries Covered | Kingdom of Saudi Arabia, United Arab Emirates (UAE), Kuwait, Qatar, Oman, Bahrain |
| Key Players influencing the GCC Medical Gloves Market | Paul Hartmann AG, Hotpack Packaging Industries LLC, Falcon (Falcon Pack), Deeko Bahrain, Salalah Medical Supplies Mfg. Co. LLC, United Medical Industries, NAFA Enterprises Ltd., Liberty Industries, Inc., Ansell Healthcare, McKesson Corporation, Cardinal Health, Inc., Medline Industries, Inc., Dynarex Corporation, Top Glove Corporation Berhad, Kimberly-Clark Corporation, Semperit AG Holding |
| Additional Attributes | Dollar sales by value, market share analysis by region, and country-wise analysis |
The market is expected to reach USD 218.61 million by 2035, growing from USD 174.15 million in 2025, at a CAGR of 2.3% during the forecast period.
The chemotherapy gloves segment is growing fastest, driven by rising cancer incidence and demand for high-protection gloves.
Examination gloves contribute most, projected to hold a 67.5% market share in 2025 due to widespread diagnostic and procedural use.
Key drivers include healthcare infrastructure expansion, infection control mandates, rising surgical procedures, and growing outpatient care.
Top companies include Paul Hartmann AG, Hotpack Packaging Industries LLC, Falcon Pack, Deeko Bahrain, Salalah Medical Supplies, and Ansell Healthcare.
Explore Medical Supplies Insights
GCC Medical Gloves Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
